INDXX MICROSECTORS™ NORTH AMERICAN CANNABIS INDEX COMPONENTS*
The Indxx MicroSectors™ North American Cannabis Index is designed to track the performance of companies that provide products or services related to the medical or industrial use of cannabis or cannabis related products. The Index includes a quarterly IPO review for new issuances and a quarterly review for stocks facing potential regulatory bars to engaging in the cannabis industry. The Index selects constituents from five key sub-themes: Cultivator, Pharmaceuticals, Testing & Analytics, Industrial Hemp, and Ancillary. Companies are screened as either pure play or quasi play, depending on the percentage of revenue that is derived from cannabis or cannabis related products.
WHAT IS THE CANNABIS INDEX?
*Index rebalances monthly. Components as of 2/1/2021
4.51% Scotts Miracle-Gro
3.50% Arena Pharmaceuticals Inc
3.24% Aurora Cannabis Inc
2.82% Canopy Growth Corp
2.10% Aphria Inc
1.81% Bruker Corp
0.54% Cronos Group Inc
0.47% Cara Therapeutics Inc
9.90% Agilent Technologies Inc
9.90% AbbVie Inc
9.90% Mettler-Toledo International
9.90% Tilray Inc
9.90% Thermo Fisher Scientific Inc
9.82% Catalent Inc
9.38% PerkinElmer Inc
7.33% Waters Corp
4.98% Innovative Industrial Properties
Source: Bloomberg L.P. Data from 12/15/2017 to 1/29/2021. Past performance does not guarantee future results. The Index, was launched on 11/8/2019. The index data prior to that date is hypothetical and reflects the application of the index methodology in hindsight. The hypothetical data cannot completely account for the impact of financial risk in actual trading. Inception data for the Index is from 5/31/2017. Past historical or hypothetical data is not a guarantee of future index performance.
“Indxx” is a service mark of Indxx, LLC (“Indxx”) and has been licensed for use for certain purposes by us. The ETNs are not sponsored, endorsed, sold or promoted by Indxx. Indxx makes no representation or warranty, express or implied, to the owners of the ETNs or any member of the public regarding the advisability of investing in securities generally or in the ETNs particularly. Indxx has no obligation to take our needs or the needs of holders of the ETNs into consideration in determining, composing or calculating the Index. Indxx is not responsible for and has not participated in the determination of the timing, amount or pricing of the ETNs to be issued or in the determination or calculation of the equation by which the ETNs are to be converted into cash. Indxx has no obligation or liability in connection with the administration, marketing or trading of the ETNs.